Tafenoquine inhibits replication of SARS-Cov-2 at pharmacologically relevant concentrations in vitro
Updated: Jul 16, 2020
60 Degrees Pharmaceuticals Announces Positive Results of Cell Culture Testing of
ARAKODA (tafenoquine) for COVID-19
Find full press release in attachment below
Please find the link and attached document of the published article and findings below